- Article number:
- 2096-1340(2022)01-0098-03
- ZTFLH:
- R256.2
- Code:
- A
References:
［1］Wang W，Jiang B，Sun H，et al.Prevalence，Incidence，and Mortality of stroke in china：results from a nationwide population-based survey of 480 687 adults［J］.Circulation，2017，135(8)：759-771.
［2］Wang D，Liu J，Liu M，et al.Patterns of stroke between university hospitals and nonuniversity hospitals in mainland china：prospective multicenter hospitalbased registry study［J］.World Neurosurg，2017，98：258-265.
［3］Huang Y，Wang JG，Wei JW，et al.Age and gender variations in the management of ischaemic stroke in China［J］.Int J Stroke，2010，5(5)：351-359.
［4］郝子龙，刘鸣，李伟，等.成都卒中登记方法及3123例患者基本特征和功能结局［J］.中华神经科杂志2011，44(12)：826-831.
［5］Bordet R，Leys D，Duriez P，et al.PPARs：A potential target for a disease-modifying strategy in stroke［J］.Current Drug Targets，2013，14(7)：752-767.
［6］刘鸣，贺茂林.中国急性缺血性脑卒中诊治指南2014［J］.中华神经科杂志，2015，48(4):246-257.
［7］赵亚伟，傅天，张彦利.中医药治疗脑卒中的研究进展［J］.现代中西医结合杂志，2017，26(24):2733-2736.
［8］李雨蔓.针灸治疗脑梗死的临床研究进展［D］.北京：北京中医药大学，2016.
［9］Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB，PPARα-and PPARγin rats［J］.International Immunopharmacology，30：157-162.
［10］ Ouk T，Potey C，Gautier S，et al.PPARs：a potential target for a disease-modifying strategy in stroke［J］.Curr Drug Targets，2013，14(7)：752-767.
［11］Zhuo Y，Zhuo J.Tranilast treatment attenuates cerebral ischemia-reperfusion injury in rats through the inhibition of inflammatory responses mediated by NF-κB and PPARs［J］.Clin Transl Sci，2019，12(2)：196-202.
［12］Guo A，Yan X.PPARα agonist fenofibrate ameliorates learning and memory deficits in rats following global cerebral ischemia［J］.Mol Neurobiol,2015,52(1):601-609.
［13］Zhou H，Yang WS，Li Y，et al.Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke［J］.Naunyn’schmiederg’s Archpharmacol,2017,390(1):77-84.
［14］Gamdzyk M，Doycheva DM，Malaguit J，et al.Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats［J］.Neuropharmacology，2018，140：150-161.
［15］Liu HF.Activation of Peroxisome proliferator-activated receptor-β/δ-attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats［J］.2014，23(6)：1396-1402.
［16］Xia P，Pan Y，Zhang F，et al.Pioglitazone confers neuroprotection against ischemia-induced pyroptosis due to its inhibitory effects on HMGB-1/RAGE and Rac1/ROS pathway by activating PPARγ［J］.Nature medicine,2018,45(6):2351-2368.
［17］Bao-Shuai S，Masaki M，Jun I，et al.Attenuation of stroke damage by angiotensin Ⅱ type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation［J］.Neuroinflamation,2018,41(10):839-848.
［18］Chao X，Xiong C，Dong W，et al.Activation of peroxisome proliferator-activated receptor-β/δ-attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats［J］.Journal of Stroke & Cerebrovascular Diseases，23(6)：1396-1402.
［19］张君.多靶点PPARs激动剂的设计、合成及体外活性评价［D］.天津：天津医科大学，2018.
［20］何婧，韩江全，过氧化物酶体增殖物激活受体在缺血性脑损伤及糖尿病合并脑缺血损伤中的研究进展［J］.医学综述，2019，25(8)：148-152.
Memo
基金项目：昌吉回族自治州科技计划项目（2017S06-03）